- Home
- QUMS vs GNLX Comparison
QUMS vs GNLX Comparison
Compare QUMS & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.64
Company Overview
Basic Information| Metric | QUMS | GNLX |
|---|---|---|
| Founded | 2024 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.7M | 202.4M |
| IPO Year | 2025 | 2023 |
Fundamental Metrics
Financial Performance| Metric | QUMS | GNLX |
|---|---|---|
| Price | $10.00 | $4.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.75 |
| AVG Volume (30 Days) | 75.9K | ★ 231.7K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.92 | $1.99 |
| 52 Week High | $10.23 | $8.54 |
Technical Indicators
Market Signals| Indicator | QUMS | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.91 |
| Support Level | N/A | $4.41 |
| Resistance Level | N/A | $5.89 |
| Average True Range (ATR) | 0.00 | 0.49 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 0.00 | 14.19 |
Price Performance
Historical Comparison QUMS
GNLX
About QUMS Quantumsphere Acquisition Corp. Ordinary Shares
Quantumsphere Acquisition Corp is a newly organized blank check company.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.